Northwire Canada EditionThursday, July 23, 2026
Northwire
ALDE 2.81 +0.0% TECK 83.43 +3.4% FVI 11.85 −2.1% SUM 1.32 −0.8% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0% CCM 0.530 +1.9% SGN 0.240 −5.9% CNC 1.49 +1.4% PHNM 0.340 +4.6% LIO 0.145 −9.4% RIO 2.67 −4.5% KG 0.160 +3.2% GEN 0.065 +0.0% ECU 1.66 +9.9% ALDE 2.81 +0.0% TECK 83.43 +3.4% FVI 11.85 −2.1% SUM 1.32 −0.8% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0% CCM 0.530 +1.9% SGN 0.240 −5.9% CNC 1.49 +1.4% PHNM 0.340 +4.6% LIO 0.145 −9.4% RIO 2.67 −4.5% KG 0.160 +3.2% GEN 0.065 +0.0% ECU 1.66 +9.9%
M&A / Property

Pharmacorp Rx completes acquisition of pharmacy

PCRX · Price

Executive Summary

  • Pharmacorp Rx Inc. has completed the acquisition of a 100% interest in a pharmacy business located in Western Canada.
  • The transaction was valued at $2.4 million, paid in cash on hand, and represents the company's fourth completed pharmacy acquisition.
  • The acquisition was executed in conjunction with Pharmacorp's strategic alliance with PharmaChoice Canada Inc.

Key Details

  • Transaction Type: Acquisition of 100% interest in a pharmacy business.
  • Location: Western Canada.
  • Purchase Price: $2.4 million.
  • Consideration: Cash on hand.
  • Counterparty: Arm's-length transaction.
  • Strategic Context: Completed in conjunction with the strategic alliance agreement with PharmaChoice Canada Inc.
  • Company Milestone: This marks Pharmacorp's fourth completed pharmacy acquisition.
  • Operational Strategy: Pharmacorp intends to continue acquiring both PharmaChoice-bannered pharmacies (via the alliance) and independently owned non-PharmaChoice pharmacies, which will subsequently be operated under the PharmaChoice Canada banner.

Notable Quotes

  • "We're grateful for the trust placed in us through this acquisition and proud to welcome this pharmacy into the Pharmacorp family," said Al Simpson, executive chair of Pharmacorp. "For many owners, a pharmacy represents decades of dedication to their community. At Pharmacorp, we're committed to helping pharmacists navigate their next chapter -- whether they're planning for succession, exploring exit strategies or looking to monetize the value they've built -- while ensuring their legacy of care continues for years to come."
Read the original news release →

More from Pharmacorp Rx Inc